BRM Targeted Compounds and Related Methods of Use
JP2024541479APending Publication Date: 2024-11-08ARVINAS OPERATIONS INC +1
Patent Information
- Application Number
- JP2024531063
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-24
- Filing Date
- 2022-11-23
- Publication Date
- 2024-11-08
Smart Images

Figure 2024541479000517 
Figure 2024541479000001 
Figure 2024541479000002
Abstract
The present disclosure relates to bifunctional compounds that find utility as modulators of SMARCA2 or BRM (target proteins). In particular, the present disclosure is directed to bifunctional compounds that contain a ligand that binds to von Hippel-Lindau E3 ubiquitin ligase at one end and a moiety that binds to a target protein at the other end, placing the target protein in close proximity to the ubiquitin ligase, resulting in degradation (and inhibition) of the target protein. The present disclosure exhibits a broad range of pharmacological activities related to degradation / inhibition of target proteins. The compounds and compositions of the present disclosure treat or prevent diseases or disorders resulting from the aggregation or accumulation of target proteins.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
High-pressure preparation method of confined high-density anhydrous alkali metal polymer nitrogen Cm-NaN5
CN113387901A
BRM Targeted Compounds and Related Methods of Use
JP2021520350A
Small molecule degraders of POLYBROMO-1 (PBRM1)
JP2021522276A
WD40 repeat domain protein 5 (WDR5) degrading / disrupting compounds and methods of use
JP2021527666A
Proteolysis targeting chimera (protacs) as degraders of smarca2 and / or smarca4
WO2020078933A1
